Fortune August 22, 2024
Ani Freedman

Drugs like Ozempic and Wegovy—also known as glucagon-like peptide-1 (GLP-1) or semaglutide medications—have been linked to increased suicidal thoughts, says a new study published in JAMA Network Open on Aug. 20.

“A detected signal of semaglutide-associated suicidal ideation warrants urgent clarification,” the academic researchers noted in the study.

Using an expansive World Health Organization database of reported individual adverse reactions to medications, they conducted a disproportionality analysis of GLP-1 RAs semaglutide and liraglutide, looking for observations of suicidal thoughts, and found such thoughts to be greater than expected.

What they found was a 45% greater rate of reports of suicidal thoughts associated with semaglutide than with all the other drugs in the database.

Mixed findings in semaglutide studies

It’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Patient / Consumer, Pharma / Biotech, Provider, Trends
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article